Pharma Focus America
ThermoFisher Scientific - Go beyond the catalog

Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

22

Feb 2024

Genezen Secures Licensing Agreement with CSL for Cytegrity™ Stable Lentivirus Production System

Genezen a toptier Contract Development and Manufacturing Organization specializing in cell and gene therapy has recently unveiled its acquisition of licensing rights for the Cytegrity proprietary stable production system from CSL

22

Feb 2024

Immune-Onc Therapeutics Receives Orphan Drug Designation from US FDA for IO-202 (Anti-LILRB4) Targeting Chronic Myelomonocytic Leukemia (CMML)

ImmuneOnc Therapeutics Inc a biopharmaceutical company focusing on immunology and oncology treatments targeting myeloid cell inhibitory receptors announced today that the US Food and Drug Administration

21

Feb 2024

NextPoint Therapeutics Commences Phase 1a/b Clinical Trial for NPX887, a Novel Treatment Targeting HHLA2 to Activate Exhausted T and NK Cells in HHLA2-Positive Solid Tumors

NextPoint Therapeutics a biotechnology company in the clinical stage has disclosed the dosing of the first patient with NPX in a Phase clinical trial targeting solid tumors expressing HHLABH

21

Feb 2024

Treadwell Receives FDA Orphan Designation for Ocifisertib, a Novel PLK4 Inhibitor, Targeting Acute Myeloid Leukemia

Treadwell Therapeutics a company specializing in developing innovative cancer treatments announced today that the US Food and Drug Administration has granted orphan drug designation to ocifisertib

21

Feb 2024

Monopar Granted Clearance for First-in-Human Phase 1 Trial of MNPR-101-Zr, a Novel Radiopharmaceutical Targeting Advanced Cancers

Monopar Therapeutics Inc has announced the clearance from the Human Research Ethics Committee in Australia to initiate a Phase dosimetry trial of its novel radiopharmaceutical MNPRZr This Phase trial

20

Feb 2024

Iterion Therapeutics Initiates Phase 1b/2a Clinical Trial for Tegavivint in Advanced Hepatocellular Carcinoma Patients who have Previously Received Systemic Treatments

Iterion Therapeutics a biopharmaceutical company specializing in oncology has announced the active enrollment of a Phase ba clinical trial

press releasesRead more...

Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Coherus BioSciences Inctoday announced the launch of UDENYCA ONBODY the companys onbody injector presentation of UDENYCA is successfully underway

Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19

BIOXYTRAN INC a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases announced that the first patients have been treated with ProLectinM in its dose optimization trial

PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1

PepGen Inc a clinicalstage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases

TECVAYLI® (Teclistamab-cqyv) Biweekly Dosing Approved by the U.S. FDA for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Johnson Johnson announced today that the US Food and Drug Administration has approved the supplemental Biologics License Application for TECVAYLI for a reduced dosing frequency of mgkg every two weeks

26 - 28

Feb 2024

26 - 28

Feb 2024

27 - 29

Feb 2024

28 - 29

Feb 2024

05 - 07

Mar 2024

05 - 07

Mar 2024

Pharma IPR Conference

Maharashtra, India

06 - 07

Mar 2024

11 - 12

Mar 2024
Testing The WorldCelebrating 70 Years of Nalgene
Sartorius Lab Balance Cleaning
Equinix accelerated medical research...
Searching for an end-to-end patient tech solution?
Thermo Fisher Scientific - Powering the future together

TOP ARTICLES

  • 1

    10 Reasons to Consider Placebo Use in Clinical Trials

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    What Are The Latest Developments In Manufacturing Technologies For Small Molecule Drugs?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    Why Are Nanotechnology Applications Important In Pharma Drug Delivery Systems?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Mass Spectrometry Techniques in Pharmaceutical Analysis: A Pathway to Improved Drug Quality

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    Is Digital Transformation the Key to Pharma's Operational Excellence?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues